Showing results 2 to 5 of 5
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection Journal:New England Journal of Medicine | 2015 | ||
Sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks in genotype 1, 2, 4, 5, 6 HCV patients: ASTRAL-1 study Proceeding/Conference:Hepatology International | 2016 | ||
2016 | |||
2017 |